Journey Medical (DERM) Debt to Equity: 2020-2025
Historic Debt to Equity for Journey Medical (DERM) over the last 4 years, with Sep 2025 value amounting to $0.97.
- Journey Medical's Debt to Equity fell 46.35% to $0.97 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.48, marking a year-over-year increase of 92.39%. This contributed to the annual value of $1.24 for FY2024, which is 72.53% up from last year.
- Latest data reveals that Journey Medical reported Debt to Equity of $0.97 as of Q3 2025, which was down 25.55% from $1.30 recorded in Q2 2025.
- In the past 5 years, Journey Medical's Debt to Equity registered a high of $1,988 during Q2 2023, and its lowest value of -$1.28 during Q3 2021.
- Its 3-year average for Debt to Equity is $200.11, with a median of $1.27 in 2024.
- In the last 5 years, Journey Medical's Debt to Equity soared by 467,596.73% in 2023 and then crashed by 99.91% in 2024.
- Quarterly analysis of 5 years shows Journey Medical's Debt to Equity stood at $0.02 in 2021, then skyrocketed by 6,843.66% to $1.34 in 2022, then tumbled by 46.42% to $0.72 in 2023, then spiked by 72.53% to $1.24 in 2024, then crashed by 46.35% to $0.97 in 2025.
- Its Debt to Equity stands at $0.97 for Q3 2025, versus $1.30 for Q2 2025 and $1.16 for Q1 2025.